Oncology conferences have become more than scientific gatherings, they are now strategic platforms for diagnostics companies. Every major oncology conference presents a surge of new data, competitor activities, partnership opportunities, and see shifts in clinical and market direction. For diagnostics companies working in areas like molecular testing, liquid biopsies, biomarker discovery, and companion diagnostics, conference analytics can influence everything from R&D priorities to commercial strategy. ... Read this blog
Recommended
